Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning

Research output: Contribution to journalJournal articleResearchpeer-review

Thomas Thymann, I Le Huërou-Luron, Y M Petersen, Mette Skou Hedemann, J Elinf, B B Jensen, Jens Juul Holst, Bolette Hartmann, Per Torp Sangild

Transition from sow's milk to solid feed is associated with intestinal atrophy and diarrhea. We hypothesized that the intestinotrophic hormone glucagon-like peptide 2 (GLP-2) would induce a dose- and health status-dependent effect on gut adaptation. In Exp. 1, weaned pigs (average BW at weaning 4.98 ± 0.18 kg) were kept in a high-sanitary environment and injected with saline or short-acting GLP-2 (80 μg/(kg BW·12 h); n = 8). Under these conditions, there was no diarrhea and GLP-2 did not improve gastrointestinal structure or function. In Exp. 2, weaned pigs (average BW at weaning 6.68 ± 0.27 kg) were kept in a low-sanitary environment, leading to weaning diarrhea, and injected with saline or short-acting GLP-2 (200 µg/(kg BW·12 h); n = 11). Treatment with GLP-2 increased goblet cell density (P 20,000 pmol/L) and Exp. 2 (increases to 20,000 pmol/L for a few hours each day) while they were in the supraphysiological range in Exp. 1 (50-200 pmol/L). In conclusion, GLP-2 may improve gut structure and function in weanling pigs. However, the effects may be significant only under conditions of diarrhea and if GLP-2 exposure time is extended using long-acting analogues.
Original languageEnglish
JournalJournal of Animal Science
Volume92
Issue number5
Pages (from-to)2070-2079
Number of pages10
ISSN0021-8812
DOIs
Publication statusPublished - 2014

ID: 109556497